Skip to content
healthcare.dev

Etoposide

NDC 71288-175, Etoposide, injection, solution, concentrate, from Meitheal Pharmaceuticals Inc..

Product NDC
71288-175
Status
Listed
Labeler
Meitheal Pharmaceuticals Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074529
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71288-175 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ETOPOSIDE20 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
71288-175-05712880175051 VIAL, MULTI-DOSE in 1 CARTON (71288-175-05) / 5 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/50491106-dddd-4efd-bd83-060e7947a244
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71288-175

Use it

Look up 71288-175 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71288-175 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71288-175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.